Literature DB >> 29781414

Prevalence of human papillomavirus types associated with cervical lesions in Sergipe state, Northeastern Brazil: high frequency of a possibly carcinogenic type.

I G S S Serra1, E D Araujo1, G S Barros1, F L S G Santos1, R Q Gurgel2, M V A Batista1.   

Abstract

Persistent infection with high-risk human papillomavirus (HPV) is the main cause of cervical cancer and the prevalence of HPV types varies depending on the geographic region. Therefore, this study assessed the prevalence of HPV types in women with cervical lesions from Sergipe state, Northeastern Brazil. A cross-sectional study was conducted in women with cervical lesions from March to December 2014. These lesions were investigated by PCR and HPV types were identified by DNA sequencing. 432 patients were included, of which 337 patients tested positive for HPV. Eighteen different HPV types were detected, and high-risk HPV types were detected in 69.2%. HPV 16 (63.4%) was the most prevalent HPV type found, followed by HPV 66 (4.6%), HPV 18 (1.6%) and HPV 45 (1.4%). These results highlight the importance of the high prevalence of HPV 66, which is a possibly carcinogenic virus type not covered by the available vaccines. The prevalence of HPV 16 was high in the studied population, reaffirming the importance of young vaccination. However, the high prevalence of HPV 66 found in this study shows the importance of monitoring the diversity of HPV types in different populations and geographic regions to better understand the impacts of current HPV vaccines.

Entities:  

Keywords:  Cervical cancer; HPV prevalence; human papillomavirus; molecular diagnosis; molecular epidemiology

Mesh:

Substances:

Year:  2018        PMID: 29781414      PMCID: PMC9134353          DOI: 10.1017/S095026881800105X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  48 in total

1.  High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study.

Authors:  Shikha Srivastava; Sadhana Gupta; Jagat Kumar Roy
Journal:  J Biosci       Date:  2012-03       Impact factor: 1.826

Review 2.  Cervical HPV infection in Brazil: systematic review.

Authors:  Andréia Rodrigues Gonçalves Ayres; Gulnar Azevedo e Silva
Journal:  Rev Saude Publica       Date:  2010-10       Impact factor: 2.106

3.  Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.

Authors:  José Veríssimo Fernandes; Rosely de Vasconcellos Meissner; Maria Goretti Freire Carvalho; Thales Allyrio Araújo de Medeiros Fernandes; Paulo Roberto Medeiros Azevedo; Judson Weber Veríssimo de Azevedo; Josélio Maria Galvão de Araújo
Journal:  Mol Med Rep       Date:  2011-09-01       Impact factor: 2.952

Review 4.  The Staden sequence analysis package.

Authors:  R Staden
Journal:  Mol Biotechnol       Date:  1996-06       Impact factor: 2.695

Review 5.  Reducing HPV-associated cancer globally.

Authors:  Douglas R Lowy; John T Schiller
Journal:  Cancer Prev Res (Phila)       Date:  2012-01

6.  Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women.

Authors:  S A Lippman; M C A Sucupira; H E Jones; C G Luppi; J Palefsky; J H H M van de Wijgert; R L S Oliveira; R S Diaz
Journal:  Int J STD AIDS       Date:  2010-02       Impact factor: 1.359

7.  High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia.

Authors:  Patti Kay; Robbert Soeters; James Nevin; Lynette Denny; Catherine M C Dehaeck; Anna-Lise Williamson
Journal:  J Med Virol       Date:  2003-10       Impact factor: 2.327

8.  Prevalence of HPV infection by cervical cytologic status in Brazil.

Authors:  José Veríssimo Fernandes; Rosely de Vasconcellos Meissner; Maria Goretti Freire de Carvalho; Thales Allyrio Araújo de Medeiros Fernandes; Paulo Roberto Medeiros de Azevedo; Luisa Lina Villa
Journal:  Int J Gynaecol Obstet       Date:  2009-01-15       Impact factor: 3.561

9.  Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies.

Authors: 
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

10.  Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort.

Authors:  Xavier Castellsagué; Michael Pawlita; Esther Roura; Núria Margall; Tim Waterboer; F Xavier Bosch; Silvia de Sanjosé; Carlos Alberto Gonzalez; Joakim Dillner; Inger T Gram; Anne Tjønneland; Christian Munk; Valeria Pala; Domenico Palli; Kay-Tee Khaw; Ruanne V Barnabas; Kim Overvad; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Guy Fagherazzi; Rudolf Kaaks; Annekatrin Lukanova; Annika Steffen; Antonia Trichopoulou; Dimitrios Trichopoulos; Eleni Klinaki; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H B As Bueno-de-Mesquita; Petra H Peeters; Eiliv Lund; Elisabete Weiderpass; J Ramón Quirós; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Nerea Larrañaga; Johanna Ekström; Maria Hortlund; David Lindquist; Nick Wareham; Ruth C Travis; Sabina Rinaldi; Massimo Tommasino; Silvia Franceschi; Elio Riboli
Journal:  Int J Cancer       Date:  2014-01-06       Impact factor: 7.396

View more
  1 in total

1.  Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.

Authors:  Monserrat Balanda; Jorge Fernández; Nicolás Vergara; Constanza Campano; Loredana Arata; Héctor San Martín; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2019-06-04       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.